What department should I register for cardiomyopathy?

Written by Zhang Yue Mei
Cardiology
Updated on September 13, 2024
00:00
00:00

Myocardial disease is a common and frequently occurring disease in clinical practice, caused by various reasons leading to pathological changes in the myocardium. Common causes include viral infections, immune system disorders, and other factors, which can lead to degeneration, necrosis, fibrosis, and interstitial edema of the myocardium. This can cause heart failure, arrhythmias, and in severe cases, even death. Therefore, early diagnosis and timely treatment can save patients' lives and alleviate their suffering. It is necessary to consult with a psychiatrist, undergo relevant examinations under the guidance of a psychiatrist, make a clear diagnosis, and actively treat and rescue the patients.

Other Voices

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 15sec home-news-image

Treatment of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, due to unknown causes and often related to genetic factors, is difficult to prevent. It is important to guide patients on how to lead their lives, reminding them to avoid intense physical activities, heavy lifting, or breath-holding to reduce the incidence of sudden death. Avoid using drugs that enhance myocardial contractility and reduce cardiac capacity load, such as digoxin and nitrates, to decrease the aggravation of left ventricular outflow tract obstruction. The treatment principle for this disease is to slow down the hypertrophy of the myocardium, prevent tachycardia, and maintain normal sinus rhythm. It also aims to relieve the narrowing of the left ventricular outflow tract and counteract arrhythmias. Currently, the use of beta blockers and calcium channel blockers is advocated. For severe obstructive patients, interventional and surgical treatments can be carried out, including the implantation of a dual-chamber DTD pacemaker, and the ablation or removal of hypertrophied interventricular septum myocardium.

doctor image
home-news-image
Written by Liu Ying
Cardiology
1min 15sec home-news-image

What should be noted for dilated cardiomyopathy?

Patients with dilated cardiomyopathy should actively look for the cause of the disease and provide corresponding treatments, such as controlling infections, strictly limiting or abstaining from alcohol, treating relevant endocrine or autoimmune diseases, correcting electrolyte disorders, and improving nutritional imbalances, etc. In the early stages of dilated cardiomyopathy, although there is already enlargement of the heart and impairment of contractile function, there are no clinical manifestations of heart failure. At this stage, early pharmacological intervention should be actively implemented to slow down ventricular remodeling and further damage to the myocardium, delaying the progression of the disease. As the condition progresses, the patient's ventricular contractile function further decreases and clinical manifestations of heart failure appear. At this point, treatment should follow the guidelines for chronic heart failure. However, the specifics of the treatment and the choice of medication should be determined by a specialist based on the patient’s condition.

doctor image
home-news-image
Written by Zhang Yue Mei
Cardiology
39sec home-news-image

Can people with cardiomyopathy run?

Whether a person with myocardial disease can run or not depends on the extent of myocardial damage and clinical symptoms. If the myocardial damage is severe and there are significant clinical symptoms of heart failure and arrhythmia, this group should not run and needs bed rest. If strenuous activity would worsen heart failure, the myocardial damage is mild, with no typical clinical symptoms, and does not affect daily activities, this group can engage in appropriate exercises like walking or running, but the duration should not be too long, about 20 to 30 minutes each time.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 14sec home-news-image

What is the prognosis of hypertrophic cardiomyopathy?

The prognosis of hypertrophic cardiomyopathy varies greatly, and it is the primary cause of sudden death in adolescents and athletes because it can progress to end-stage heart failure. Additionally, a small percentage may experience heart failure, atrial fibrillation, and embolism, but many patients have mild symptoms and can have a life expectancy close to normal. For the treatment of hypertrophic cardiomyopathy, adequate sudden death risk assessment and ICD prevention should be conducted. Because hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young people and athletes, an ICD can effectively prevent the occurrence of sudden death. Preventing high-risk factors, including previous cardiac arrest, one or more sudden deaths in first-degree relatives, severe left ventricular hypertrophy, and findings of repetitive non-sustained ventricular tachycardia on a 24-hour Holter monitor, low blood pressure during exercise, and unexplained syncope, especially during exercise, poses a high risk of sudden death in these patients.

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
42sec home-news-image

Which department should I register for cardiomyopathy?

Cardiomyopathy is a common disease in our daily lives, characterized primarily by changes in the myocardium. After being diagnosed with cardiomyopathy, many patients often ask which department they should register with at the hospital. Generally speaking, cardiomyopathy falls under cardiovascular diseases, so registration should be with the department of cardiology. Cardiologists often prescribe a cardiac echocardiogram to diagnose myocardial diseases. Conditions such as hypertrophic cardiomyopathy or dilated cardiomyopathy require a cardiac echocardiogram for detection, which is the most commonly used examination for cardiomyopathy.